Palo Alto Capital

Palo Alto Capital is a Silicon Valley-based private investment firm focused on growth and later-stage investing rather than drug development or healthcare operations. The firm describes its strategy as backing breakthrough technologies across artificial intelligence, deep tech, decarbonization, and consumer technology, including pre-IPO opportunities. It emphasizes cross-border networks between the U.S. and Asia and provides capital along with strategic and operational support. Based on the available public information, Palo Alto Capital is not a biotech, pharma, or healthcare company and does not appear to operate a therapeutic pipeline.